Disease

Neuroendocrine Carcinoma

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 12, 2026 · OBSERVATIONAL STUDY

The Molecular Screening Study for the Umbrella Trial (SUKSES) in Relapsed Small Cell Lung Cancer Patients [SUKSES-S]

ClinicalTrials.gov

This is a registry record for an ongoing molecular screening study with no reported results; it describes planned enrollment and methodology only, making it a feasibility and characterization effort preceding intervention trials.

PreliminarySamsung Medical Center Neuroendocrine Carcinoma No treatment is included in this protocol.

Reported

Estimated enrollment797

Primary outcome measureRatio of each molecular subtypes

AUG 10, 2026 · PHASE 1 TRIAL

NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas

ClinicalTrials.gov

Phase 1 pilot study with small enrollment (n=15) testing a novel three-drug combination in advanced neuroendocrine carcinoma; no results posted in this registry record.

PreliminaryNeuroendocrine Carcinoma Amr Mohamed MD NCT05262556

Reported

Planned enrollment15

Study phasePhase 1

Primary outcome measureAntitumor activity of NP-101 (TQ Formula) p…